Gold Silver Reports (GSR) – Dr. Reddy’s Lab Gains After FDA Inspection Concludes – Shares of the drugmaker rose as much as 3.8 percent to Rs 2,013.85. The U.S drug regulator concluded inspection at the pharmaceutical company’s Srikakulam Plant with no observations.